RESEARCH TRIANGLE PARK, NC--(Marketwired - June 08, 2016) - Top ten pharmaceutical companies' country-level affiliate HEOR department heads claimed the greatest annual salaries at an average base pay of $350,000 with a potential $193,000 in bonus compensation, according to a study published by Cutting Edge Information. These department heads' average base salaries alone exceed the potential maximum compensation of all other affiliate-level HEOR team members.

The study, Building World-Class HEOR Teams: Creating Convincing Value Propositions for Payers, found that among top ten companies' country-level affiliate HEOR executives, management positions have higher earnings than HOLs and HOER analysts. Entry-level HOLs have the lowest average salary and bonus combination at an estimated $123,000. Experienced HOLs generate an average annual income of approximately $136,000.

"There is a wide range of salaries reported from country-level affiliate groups, especially in comparison to their global counterparts," said Jacob Presson, data product team leader at Cutting Edge Information. "Top 50 HEOR teams' tier management positions average $117,000 per year while Top 10 country-level department heads make around $443,000 per year."

Top 10 companies' HEOR analysts could potentially earn higher compensation in a year compared to experienced HOLs; $141,000 compared to $136,000. However, HOLs have a higher annual salary -- an average of $130,000 compared to analysts who average $119,000.

Aside from providing salary data for health economics and outcomes research teams, Building World-Class HEOR Teams: Creating Convincing Value Proposition for Payers, available at, highlights HEOR group structure, staffing and spending at pharmaceutical and medical device companies around the world. The report's resource metrics allow health economics groups to benchmark their activities against the rest of the industry and to ensure that they are effectively supporting their products. Highlights include:

  • Benchmarks showing HEOR spending from 2013 to 2015 per company and on a per-product basis.
  • Data showing HEOR group oversight, leadership and funding sources.
  • Executive perspectives on demonstrating the value of HEOR internally.
  • Insights on how to ensure that stakeholders beyond payers are understood when developing health economics research.

For other benchmarking research on market access teams, view Cutting Edge Information's market access library at

Image Available:,_by_Pos-c0db1ae93142b30ebb06fbfbe31d1e13.jpg

Contact Information:

Elio Evangelista
Senior Director of Commercialization
Cutting Edge Information